Healthcare Sector Actividad de insiders

Sigue las compras y ventas de insiders en acciones de Healthcare. Descubre qué ejecutivos compran, la actividad neta de insiders y el % del capital flotante negociado en 3,224 empresas.
La información que se muestra en esta pantalla tiene fines meramente informativos y no constituye asesoramiento financiero. No recomendamos ninguna inversión específica basándonos en estos criterios.
Empresas
Datos
Suscríbase para acceder a todos los datos.
Compañía Sector empresarial Capitalización de mercado ($) # Compras netas de insiders Valor neto de la compra ($) % de flotación comprada % de acciones en manos de insiders
Pharmaceuticals & Medical Research Mid (6.3bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (6.2bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (6.2bn) -1–5 -$1M–$10M -0–15% 15–50%
Healthcare Services Mid (6.1bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.1bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (6.1bn) -1–5 -$1M–$10M -0–15% 0–15%
US Teleflex Inc (TFX)
Healthcare Services Mid (6.1bn) 0 No hay actividad — 0–15%
US R1 RCM Inc (RCM)
Healthcare Services Mid (6.0bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (6.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mid (6.0bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (6.0bn) 0 No hay actividad — 0–15%
Healthcare Services Mid (5.9bn) -1–5 -$100K–$1M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (5.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.7bn) 0 No hay actividad — 0–15%
SE Sectra AB (SECT-B)
Healthcare Services Mid (5.6bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (5.5bn) 0 No hay actividad — 0–15%
Healthcare Services Mid (5.5bn) -6–10 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.4bn) 0 No hay actividad — 0–15%
Healthcare Services Mid (5.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (5.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.3bn) 0 No hay actividad — 50%+
US LHC Group Inc (LHCG)
Healthcare Services Mid (5.3bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (5.3bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (5.3bn) 0 No hay actividad — 0–15%
US Celcuity Inc (CELC)
Pharmaceuticals & Medical Research Mid (5.2bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.1bn) 0 No hay actividad — 15–50%
Pharmaceuticals & Medical Research Mid (5.1bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) 0 No hay actividad — 50%+
Pharmaceuticals & Medical Research Mid (5.0bn) -1–5 -< $100K -0–15% 50%+
Healthcare Services Mid (5.0bn) 0 No hay actividad — 50%+
Healthcare Services Mid (4.9bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (4.9bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.8bn) -1–5 -< $100K -0–15% 0–15%
IN Ajanta Pharma Ltd (AJANTPHARM)
Pharmaceuticals & Medical Research Mid (4.8bn) -1–5 -$100M+ -0–15% 50%+
Pharmaceuticals & Medical Research Mid (4.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (4.7bn) -6–10 -$100M+ -0–15% 0–15%
Healthcare Services Mid (4.7bn) 0 No hay actividad — 0–15%
US Veracyte Inc (VCYT)
Pharmaceuticals & Medical Research Mid (4.7bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (4.7bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) 0 No hay actividad — 15–50%
Pharmaceuticals & Medical Research Mid (4.6bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (4.6bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No hay actividad — 0–15%
Healthcare Services Mid (4.5bn) 0 No hay actividad — 0–15%
US LivaNova PLC (LIVN)
Healthcare Services Mid (4.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Mid (4.5bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No hay actividad — 0–15%
Healthcare Services Mid (4.4bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (4.4bn) 0 No hay actividad — 0–15%
Healthcare Services Mid (4.4bn) 0 No hay actividad — 50%+
Pharmaceuticals & Medical Research Mid (4.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.3bn) 0 No hay actividad — 0–15%
IN Biocon Ltd (BIOCON)
Pharmaceuticals & Medical Research Mid (4.3bn) 0 No hay actividad — 50%+
Healthcare Services Mid (4.2bn) 0 No hay actividad — 0–15%
GB Indivior PLC (INDV)
Pharmaceuticals & Medical Research Mid (4.2bn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Mid (4.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US RadNet Inc (RDNT)
Healthcare Services Mid (4.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US Alkermes Inc (ALKS)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No hay actividad — 0–15%
US TESARO Inc (TSRO)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No hay actividad — —
US Metsera Inc (MTSR)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) -1–5 -< $100K -0–15% 15–50%
Healthcare Services Mid (4.1bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) -1–5 -$10M–$100M -0–15% 0–15%
US Heartflow Inc (HTFL)
Healthcare Services Mid (4.1bn) 0 No hay actividad — 0–15%
Healthcare Services Mid (4.1bn) 0 No hay actividad — 50%+
Pharmaceuticals & Medical Research Mid (4.0bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) 0 No hay actividad — 0–15%
SE Medicover AB (MCOV-B)
Healthcare Services Mid (3.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 No hay actividad — 0–15%
SE Camurus AB (CAMX)
Pharmaceuticals & Medical Research Mid (3.8bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 No hay actividad — 0–15%
US Perrigo Co (PRGO)
Pharmaceuticals & Medical Research Mid (3.8bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No hay actividad — 15–50%
Pharmaceuticals & Medical Research Mid (3.7bn) 1–5 $1M–$10M 0–15% 15–50%
Healthcare Services Mid (3.7bn) -1–5 -$1M–$10M -0–15% 15–50%
Healthcare Services Mid (3.6bn) 0 No hay actividad — 0–15%
Healthcare Services Mid (3.6bn) 0 No hay actividad — 0–15%
US Organon & Co (OGN)
Pharmaceuticals & Medical Research Mid (3.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.6bn) 0 No hay actividad — 50%+
US CorVel Corp (CRVL)
Healthcare Services Mid (3.6bn) -1–5 -$1M–$10M -0–15% 15–50%
US Grail Inc (GRAL)
Pharmaceuticals & Medical Research Mid (3.6bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 No hay actividad — 0–15%
Healthcare Services Mid (3.5bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 No hay actividad — 50%+
Pharmaceuticals & Medical Research Mid (3.5bn) 0 No hay actividad — 0–15%
US Alumis Inc (ALMS)
Pharmaceuticals & Medical Research Mid (3.5bn) -1–5 -$100K–$1M -0–15% 0–15%